Odyssey Health (ODYY) Short term Debt (2019 - 2026)

Odyssey Health (ODYY) reported Short term Debt of $2.4 million for Q2 2026, down 38.25% sequentially from $3.9 million in Q1 2026.

Odyssey Health (ODYY) Short term Debt (2019 - 2026) Analysis & Trends

Odyssey Health has disclosed Short term Debt across 4 years of filings, most recently posting $2.4 million for Q2 2026.

Quarterly Short term Debt changed N/A year-over-year to $2.4 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.4 million (changed N/A YoY) and the FY2019 annual result came in at $144000.0, changed N/A from the prior year.
Short term Debt fell to $2.4 million in Q2 2026, from $3.9 million in the prior quarter.
Across five years, Short term Debt topped out at $3.9 million in Q1 2026 and bottomed at $225155.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Odyssey Health	-	-	-

Download Data